China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'MRI-Based Radiomics for Preoperative Discrimination Between Ductal Carcinoma In Situ and Low-Grade Invasive Ductal Carcinoma: Added Value and Clinical Implications of Peritumoral Features'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136732
Registration Time: 2026/11/15
Type: Diagnostic test
Primary Sponsor: Suzhou Municipal Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=326930
Published by HT Digital Content Services with permission from Health Daily Digest....